Background: We had hypothesised that retinaldehyde (RAL) should be an inter
esting precursor for topical use. Aim: We review our observations about its
biological activities. Methods: We performed pilot studies to explore its
biological effects and tolerability in human skin and compared the effects
of topical RAL to that of all-trans-retinoic acid (RA) in the mouse tail te
st. Results: The biological activities of RAL were found to be qualitativel
y identical to that of RA: (i) induction of cellular RA-binding protein typ
e 2 mRNA and protein, (ii) increase in epidermal proliferation (increase in
DNA synthesis, epidermal thickness, induction of 50-kD keratin mRNA and re
duction in 70-kD keratin mRNA), and (iii) metaplastic effects (induction of
orthokeratosis, reduction of 65-kD keratin mRNA, increase in filaggrin and
loricrin mRNAs). When associated with RAL, citral (known for its capacity
to inhibit the oxidation of retinol to RA in epidermis) counteracted the ef
fects induced by RAL indicating that RAL exerts biological activities throu
gh transformation to RA. Hypothesising that keratinocytes would metabolize
9-cis-RAL to 9-cis-RA, we compared the biological effects induced by topica
l 9-cis-RAL and found that hyperplastic and metaplastic responses were lowe
r than those induced by all-trans-RAL or all-trans-RA at similar concentrat
ions. This suggests that 9-cis-RAL has no advantage over all-trans-RAL for
specific delivery of natural retinoids into the skin. As in clinical studie
s conducted in human skin, we also found topical RAL less irritant than RA.
Conclusion: These studies indicate that topical RAL has biological activit
y and is well tolerated.